Up next

Autoplay

Ubrelvy, Reyvow, Rimegepant, Eptinezumab: Live Q&A With Dr. Larry Robbins

0 Views • 08/28/25
Share
Side Effects
Side Effects
Subscribers
0

Join us for a Q&A with Dr. Larry Robbins of the Robbins Headache Clinic as he answers questions about the new migraine abortive medications, Ubrelvy and Reyvow, as well as two more migraine meds expected to be FDA approved 1st quarter 2020, rimegepant and eptinezumab.

For more information, please visit the following:
1. Hope for Migraine: www.facebook.com/groups/CGRPandMigraine
2. Migraine Meanderings: www.facebook.com/groups/MigraineMeanderings
3. Migraine Meanderings: www.migrainemeanderings.com
4. Robbins Headache Clinic: www.chicagoheadacheclinic.com
5. Articles on CGRP: http://chicagoheadacheclinic.c....om/articles-on-cgrp-

Show more
0 Comments sort Sort By

Up next

Autoplay